HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy
<p>Abstract</p> <p>Background</p> <p>In previously published studies, oncolytic adenovirus-mediated gene therapy has produced good results in targeting cancer cells. However, safety and efficacy, the two most important aspects in cancer therapy, remain serious challenge...
Main Authors: | Xu Hai-Neng, Huang Wei-Dan, Cai Ying, Ding Miao, Gu Jin-Fa, Wei Na, Sun Lan-Ying, Cao Xin, Li Hua-Guang, Zhang Kang-Jian, Liu Xin-Ran, Liu Xin-Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://www.molecular-cancer.com/content/10/1/133 |
Similar Items
-
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01) -
Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01) -
Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer <it>in vitro</it> and <it>in vivo</it>
by: Zhu Wei, et al.
Published: (2012-05-01) -
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
by: Martí Farrera-Sal, et al.
Published: (2020-04-01) -
Oncolytic Adenovirus in Cancer Immunotherapy
by: Malin Peter, et al.
Published: (2020-11-01)